Swan-Swan Leong

Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)

Masahiro Fukuoka, Yi‐Long Wu, Sumitra Thongprasert et al. · Journal of Clinical Oncology · 2011 · 1.6K citations

Medicine, Oncology, Pharmacotherapy +17

The Impact of Smoking Status on the Behavior and Survival Outcome of Patients With Advanced Non-small Cell Lung Cancer

Chee‐Keong Toh, Ee-Hwee Wong, Wan‐Teck Lim et al. · CHEST Journal · 2004 · 146 citations

Medicine, Oncology, Survival Analysis +4

A Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma

Wan‐Teck Lim, Quan‐Sing Ng, Percy Ivy et al. · Clinical Cancer Research · 2011 · 124 citations · Full text

Medicine, Oncology, Pharmacology +16

Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma

Donald Poon, Swee‐Peng Yap, Zee-Wan Wong et al. · International Journal of Radiation Oncology*Biology*Physics · 2004 · 51 citations

Medicine, Oncology, Radiation Oncology +14

Cisplatin-Based Three Drugs Combination (NIP) as Induction and Adjuvant Treatment in Locally Advanced Non-small Cell Lung Cancer: Final Results

Maya Gottfried, Rodryg Ramlau, Maciej Krzakowski et al. · Journal of Thoracic Oncology · 2008 · 30 citations · Full text

Medicine, Oncology, Pharmacology +12